Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06860022 · ClinicalTrials.gov registry record · NA

Sentence Shaping - DHH

A NA study of Hearing Loss, Bilateral, sponsored by Vanderbilt University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06860022: Recruiting NA study of Hearing Loss, Bilateral, sponsored by Vanderbilt University.

NCT06860022 is a NA study of Hearing Loss, Bilateral that is actively recruiting participants, run by Vanderbilt University. The registered enrollment target is 30 participants, below the 2,335-participant average among 6 other Hearing Loss, Bilateral trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06860022, a NA study of Hearing Loss, Bilateral, is actively recruiting participants, sponsored by Vanderbilt University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The proposed research addresses a long-standing and important challenge of improving literacy skills of children who are deaf and hard of hearing, a historically under researched group. The investigators aim to leverage shape coding - an empirically validated intervention approach for constructing sentences in spoken English - for improving how efficiently children who are deaf and hard of hearing learn to correctly construct sentences in written English. To advance the promising yet underutilized research on shape coding, the investigators complete the next logical step of applying the visual supports provided with shape coding to written language for deaf and hard of hearing children. Shape coding has been effective for teaching sentence structure in spoken English to children with language disabilities and has recently been applied to sentence structure in American Sign Language with deaf and hard of hearing children. Intervention involving shape coding is predicted to result in increased accuracy of word order in sentences in written English because deaf and hard of hearing children often benefit from visual information. The investigators will accomplish this aim using single case multiple probe across participants design studies with 30 fifth through eighth grade children who are deaf and hard of hearing. The knowledge gained will guide language and literacy intervention for children who are deaf and hard of hearing.

Primary Outcome

The investigators will calculate the proportion of children for whom the intervention is successful, defined as at least 80% accuracy for 3 consecutive data collection days.

Conditions Studied

Interventions

  • BEHAVIORAL Shape Coding

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-08-28
Est. Completion 2026-10
Phase NA
Vanderbilt University

430 total trials

What NCT06860022 shows while recruiting

NCT06860022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,335-participant average among 6 other Hearing Loss, Bilateral trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Hearing Loss, Bilateral appearing as the primary indexed condition, and to 1 intervention - of which Shape Coding is the first listed.

NCT06860022 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06860022 about?

NCT06860022 is a clinical study titled "Sentence Shaping - DHH". The proposed research addresses a long-standing and important challenge of improving literacy skills of children who are deaf and hard of hearing, a historically under researched group. The investigators aim to leverage shape coding - an empirically validated intervention approach for constructing s...

What is the current status of trial NCT06860022?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-28. Estimated completion is 2026-10.

What conditions does trial NCT06860022 study?

This clinical trial studies the following conditions: Hearing Loss, Bilateral.

What interventions are being tested in trial NCT06860022?

The interventions under investigation include: Shape Coding (BEHAVIORAL).

Who is sponsoring clinical trial NCT06860022?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06860022 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Bilateral

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06860022, the US trial registry maintained by the National Library of Medicine. NCT06860022 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.